BTMD· Health Care› Medical Care Facilities

Biote Corp. Class A

Stage 4 · Declining · week 10

As of Oct 22, 2026, Biote is in Stage 4, the downtrend phase, now in week 10 (since Aug 14, 2026). It closed at $1.09, 65.8% below its 52-week high and below its 200-day average, which is falling.

biote Corp. operates in practice-building business within the hormone optimization space. More about the company

$1.09

+5.83% today

$37.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is BTMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 13w

S2 20w

S4 19w

S4 38w

S1 14w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 2w → S3 6w → S4 5w → S1 3w → S4 13w → S1 5w → S2 20w → S3 6w → S4 8w → S1 9w → S4 19w → S1 8w → S4 38w → S1 14w → S4 10w current

Total tracked: 166 weeks across 15 stage runs.

BTMD among Medical Care Facilities42nd of 49 by relative strength

All 49 →

Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AGLagilon health, inc.	Stage 3 · wk 8	98	+6.8%
2	PACSPACS Group, Inc.	Stage 3 · wk 4	98	+15.7%
3	LFSTLifeStance Health Group, Inc.	Stage 2 · wk 24	97	+4.0%
4	AMNAMN Healthcare Services Inc	Stage 2 · wk 25	96	+38.1%
5	NHCNational HealthCare Corporation	Stage 2 · wk 59	95	+8.4%
6	CONConcentra Group Holdings Parent, Inc.	Stage 2 · wk 22	94	+14.9%
7	INNVInnovAge Holding Corp.	Stage 3 · wk 5	93	+5.8%
8	MDPediatrix Medical Group, Inc.	Stage 2 · wk 26	92	+14.3%
…42	BTMDBiote Corp. Class A	Stage 4 · wk 10	17	−16.2%

vs 52W High

-65.8%

$1.03 lo$3.19 hi

65.8% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 10

1w13w26w

Week 10, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-41.7%

200 DMA: $1.87 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.51x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-16.2%

-52.2%

-50.9%

YTD

-55.9%

-64.5%

Scan Membership

Breakout Watch

Latest: 2024-04-11

3 appearances in last 60 days. First seen: 2022-02-09.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 10 · Vol 0.51x

2026-10-21S4

Wk 10 · Vol 0.61x

2026-10-20S4

Wk 10 · Vol 0.19x

2026-10-19S4

Wk 10 · Vol 0.34x

2026-10-16S4

Wk 9 · Vol 0.17x

2026-10-15S4

Wk 9 · Vol 0.18x

2026-10-14S4

Wk 9 · Vol 0.61x

2026-10-13S4

Wk 9 · Vol 1.67x

2026-10-12S4

Wk 9 · Vol 0.27x

2026-10-09S4

Wk 8 · Vol 0.19x

2026-10-08S4

Wk 8 · Vol 0.60x

2026-10-07S4

Wk 8 · Vol 0.81x

Moving averages & range

50 DMA

$1.33

200 DMA

$1.87

52W High

$3.19

52W Low

$1.03

5D Low

$1.03

Resistance levels (recent highs)

20d High

$1.24

60d High

$2.29

120d High

$2.52

250d High

$2.93

Next resistance

+13.8%

to 20d High

P/E (TTM)

7.8

Forward 2.4

Dividend Yield

0.00%

P/B -0.5

Biote: quick answers

What stage is Biote in?

As of Oct 22, 2026, Biote (BTMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 14, 2026 and is in week 10. What the four stages mean

Is Biote in an uptrend?

No. Biote is in a Stage 4 downtrend. It trades 41.7% below its 200-day average, which is falling.

How far is Biote from its 52-week high?

Biote closed at $1.09 on Oct 22, 2026, 65.8% below its 52-week high of $3.19. Its 52-week low is $1.03.

How has Biote performed over the past year?

As of Oct 22, 2026, Biote is down 64.5% over the past year and down 55.9% so far in 2026.

Which sector and industry is Biote in?

Biote is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.